Cabozantinib plus atezolizumab in advanced hepatocellular carcinoma and the role of adjuvant antiviral therapy

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Access to Document

@article{9369afac4e4542bd9fac6312e3e12d85,

title = "Cabozantinib plus atezolizumab in advanced hepatocellular carcinoma and the role of adjuvant antiviral therapy",

author = "Fanpu Ji and Nguyen, \{Mindie H.\}",

year = "2022",

month = aug,

doi = "10.1016/S1470-2045(22)00383-7",

language = "英语",

volume = "23",

pages = "962--963",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "8",

}

TY - JOUR

T1 - Cabozantinib plus atezolizumab in advanced hepatocellular carcinoma and the role of adjuvant antiviral therapy

AU - Ji, Fanpu

AU - Nguyen, Mindie H.

PY - 2022/8

Y1 - 2022/8

UR - https://www.scopus.com/pages/publications/85134764939

U2 - 10.1016/S1470-2045(22)00383-7

DO - 10.1016/S1470-2045(22)00383-7

M3 - 评论/辩论

C2 - 35798015

AN - SCOPUS:85134764939

SN - 1470-2045

VL - 23

SP - 962

EP - 963

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 8

ER -